Bioray Laboratories
Clinical trials sponsored by Bioray Laboratories, explained in plain language.
-
Universal Cancer-Fighting cells tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing whether a new type of cancer treatment called universal CAR-T cells is safe and effective for adults with multiple myeloma that has returned or stopped responding to other treatments. The treatment uses specially engineered immune cells from donors (not the …
Phase: NA • Sponsor: Bioray Laboratories • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Early trial tests 'Off-the-Shelf' cell therapy for tough lymphoma
Disease control Recruiting nowThis is an early-stage study testing a new type of cell therapy called universal CAR-T for adults with B-cell Non-Hodgkin Lymphoma that has come back or not responded to other treatments. The main goal is to check if the treatment is safe and see if it helps control the cancer. I…
Phase: NA • Sponsor: Bioray Laboratories • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for Tough-to-Treat lymphoma: early trial tests Next-Gen cell therapy
Disease control Recruiting nowThis early-stage study is testing the safety and finding the right dose of a new type of CAR-T cell therapy called BRL-201 for adults with aggressive B-cell non-Hodgkin lymphoma that has come back or not responded to other treatments. The therapy involves collecting a patient's o…
Phase: PHASE1 • Sponsor: Bioray Laboratories • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC